FUZEON

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Mexico, Poland, Romania, Spain, UK.

Active ingredients

The drug FUZEON contains one active pharmaceutical ingredient (API):

1	Enfuvirtide UNII 19OWO1T3ZE - ENFUVIRTIDE
	Enfuvirtide is a member of the therapeutic class called fusion inhibitors. It is an inhibitor of the structural rearrangement of HIV-1 gp41 and functions by specifically binding to this virus protein extracellularly thereby blocking fusion between the viral cell membrane and the target cell membrane, preventing the viral RNA from entering into the target cell.
	Read more about Enfuvirtide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FUZEON Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)
Fuzeon 90 mg/ml powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AX07	Enfuvirtide	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10365M
BR	Câmara de Regulação do Mercado de Medicamentos	529215020026002
CA	Health Products and Food Branch	02247725
EE	Ravimiamet	1203242, 1203253
ES	Centro de información online de medicamentos de la AEMPS	03252001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	014583
FR	Base de données publique des médicaments	62723129
GB	Medicines & Healthcare Products Regulatory Agency	79735
HK	Department of Health Drug Office	57518
LT	Valstybinė vaistų kontrolės tarnyba	1028609
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	562M2003
PL	Rejestru Produktów Leczniczych	100125431
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13961002, W52557001